Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
Top Cited Papers
- 27 February 2003
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (7), 1081-1111
- https://doi.org/10.1021/jm020450x
Abstract
No abstract availableThis publication has 228 references indexed in Scilit:
- Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patientsJournal of Clinical Pathology, 1999
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- A realistic clinical perspective of tamoxifen and endometrial carcinogenesisEuropean Journal of Cancer, 1996
- Effect of tamoxifen feeding on metabolic activation of tamoxifen by the liver of the Rhesus monkey: Does liver accumulation of inhibitory metabolities protect from tamoxifen-dependent genotoxicity and cancer?Carcinogenesis: Integrative Cancer Research, 1996
- Tamoxifen induces hepatocellular carcinoma in rat liver: A 1-year study with two antiestrogensArchives of Toxicology, 1993
- Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the ratJournal of Steroid Biochemistry, 1990
- Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: A model to study the tumoristatic action of tamoxifenJournal of Steroid Biochemistry, 1988
- Adjuvant tamoxifen in primary breast cancer: Influence on plasma lipids and antithrombin III levelsBreast Cancer Research and Treatment, 1988
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levelsLife Sciences, 1983